Hypertension Trial, Recruiting NCT07135505 Sponsor: University of Alabama at Birmingham Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07135505
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to give their consent to take part in the study
  • Men and women aged 60 or older
  • People whose average blood pressure reading (top number) taken at a clinic or doctor's office is 130 mmHg or higher
  • People who currently eat across a period of 12 or more hours each day, at least 5 days per week
  • People whose general health has been stable over the past 2 months

Who may not be able to join:

  • People who already fast for more than 12 hours per day
  • People who are actively trying to lose weight through a formal weight loss program or by significantly cutting calories
  • People who have lost 10 pounds or more in the last 3 months
  • People who are unable to wake up at a consistent time between 6:00 and 8:00 am
  • People who work overnight shifts more than one day per week on average
  • People with a resting heart rate above 120 beats per minute, a top blood pressure number above 180 mmHg, or a bottom blood pressure number above 100 mmHg
  • People who have been diagnosed with diabetes
  • People who take insulin or other diabetes medications
  • People who have had unstable chest pain, a heart attack, or a stroke in the past 3 months
  • People who continuously use supplemental oxygen to manage a long-term lung condition or heart failure
  • People who are pregnant or breastfeeding
  • People who have rheumatoid arthritis, Parkinson's disease, or who are currently on dialysis (a kidney treatment)
  • People who currently have a major psychiatric (mental health) condition that would make it difficult to take part in the study
  • People with severe digestive disease, a history of major digestive surgery, or active gallstone disease
  • People who have received cancer treatment in the past year
  • People whose medications cannot be taken more than 12 hours apart without food, which would make 16-hour fasting difficult or unsafe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 February 2026
Est. completion
30 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Blood glucose; Heart rate variability; Systolic Blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov